title: Second-generation antipsychotics did not improve outcomes and increased costs for patients with Alzheimer disease and psychosis.
authors.affiliation: Queen's University, Kingston, Ontario, Canada.
authors.forename: Dallas P
authors.initials: DP
authors.lastname: Seitz
authors.forename: Andrea
authors.initials: A
authors.lastname: Gruneir
authors.forename: Paula A
authors.initials: PA
authors.lastname: Rochon